Showing results (31-40 of 888) with videos related to
Sort By:
Pageof 89
Congestive Heart Failure (Greenwich, Conn.)|October 4, 2008
Cost-effectiveness of B-type natriuretic peptide testingChristian MuellerCongestive Heart Failure (Greenwich, Conn.)|August 16, 2012
Post-acute care: the role of natriuretic peptidesAlan Maisel, James Januzzi, Yang Xue, et al.Postgraduate Medicine|November 9, 2013
Neutrophil gelatinase associated lipocalin in acute kidney injuryW Frank Peacock, Alan Maisel, Jieun Kim, et al.Journal of Cardiac Failure|December 5, 2012
Patients with acute heart failure in the emergency department: do they all need to be admitted?Peter S Pang, Robert Jesse, Sean P Collins, et al.Expert Review of Cardiovascular Therapy|June 2, 2012
Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndromePam R Taub, Kelly C Borden, Arrash Fard, et al.Clinical Chemistry and Laboratory Medicine|October 24, 2012
Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic reviewDinna N Cruz, Sergio Gaiao, Alan Maisel, et al.Seminars in Nephrology|February 28, 2012
Role of biomarkers in the diagnosis and management of cardio-renal syndromesDinna N Cruz, Arrash Fard, Anna Clementi, et al.Congestive Heart Failure (Greenwich, Conn.)|October 7, 2008
Inpatient monitoring and prognostic importance of B-type natriuretic peptideNadia Aspromonte, Roberto Valle, William F Peacock, et al.The American Journal of Cardiology|August 9, 2006
Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failureYuk Ming Law, Jose Ettedgui, Lee Beerman, et al.Contributions to Nephrology|April 30, 2010
Biomarkers of cardiac and kidney dysfunction in cardiorenal syndromesDinna N Cruz, Sachin Soni, Leo Slavin, et al.Pageof 89